Professional Documents
Culture Documents
Bladmir Survey
Bladmir Survey
Address
Contact no.
The Information provided in this document is strictly confidential and is available for review to
Alembic Pharmaceuticals only. No disclosure should take place without written authorization
from Alembic Pharmaceuticals Pvt. Ltd.
Title:……………………………………………………………………………………….………………………………
Address:
Alembic Pharmaceuticals Limited,
2nd Floor, Prime Corporate Park
Behind ITC Grand Maratha Sheraton,
Sahar Road, Andheri East, Mumbai,
Maharashtra 400099
OAB Survey – Confidential
Mirabegron prescription pattern survey Alembic Pharmaceuticals Ltd
1. What percentages of OAB patients do you see daily in your clinical practice?
5%
5-10%
10-20%
>20%
2. What percentages of Female OAB patients do you see daily in your clinical
practice?
5%
5-10%
10-20%
>20%
3. Are you satisfied with the current treatment available for OAB?
Yes
No
1-3 months
3-6 months
6-12 months
>12 months
OAB Survey – Confidential
Mirabegron prescription pattern survey Alembic Pharmaceuticals Ltd
1 month
3 months
5 months
Limited efficacy
Side effects
High Cost of therapy
7. What are the treatment options do you consider for patients who do not respond
to Anticholinergic therapy or not suitable for anticholinergic therapy?
Nerve stimulation
8. Have you ever used Mirabegron as a first line therapy in your OAB patients?
Yes
No
OAB Survey – Confidential
Mirabegron prescription pattern survey Alembic Pharmaceuticals Ltd
9. If yes ----- then how many percentages of patients of OAB respond to Mirabegron
as a first line therapy?
< 25
25-50
50-75
>75
Naïve patient 0 1 2 3 4 5
Safety profile 0 1 2 3 4 5
11. Which are the factors do you consider to begin with Mirabegron & Solifenacin
combination therapy?
Safety profile 0 1 2 3 4 5
12. Which step down option do you prefer for long-term maintenance therapy in your OAB
patients who are already on Mirabegron & Solifenacin combination therapy? (tick one
option only)
Mirabegron monotherapy
Solifenacin monotherapy
Continue with reduced dose of combination therapy
13. Have your female patients has earlier consulted with any other speciality before
approaching specialist?
Yes
No
OAB Survey – Confidential
Mirabegron prescription pattern survey Alembic Pharmaceuticals Ltd
14. What would be the order of preference for first consultation of female OAB
patients towards a speciality?
Speciality % Patients
CP
Gynec
GPs
Surgeons
Urologist
Date: ………………………………………………………………………………………………………………………
Place: ………………………………………………………………………………………………………………………